A detailed history of Cetera Investment Advisers transactions in Astrazeneca PLC stock. As of the latest transaction made, Cetera Investment Advisers holds 202,333 shares of AZN stock, worth $13.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
202,333
Previous 207,497 2.49%
Holding current value
$13.1 Million
Previous $14.1 Million 12.25%
% of portfolio
0.04%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

SELL
$66.81 - $80.83 $345,006 - $417,406
-5,164 Reduced 2.49%
202,333 $15.8 Million
Q1 2024

May 24, 2024

BUY
$61.03 - $69.57 $9.85 Million - $11.2 Million
161,445 Added 350.57%
207,497 $14.1 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $817,985 - $932,446
-13,403 Reduced 22.54%
46,052 $3.12 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $566,602 - $634,258
9,155 Added 18.2%
59,455 $4 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $300,709 - $332,472
-4,637 Reduced 8.44%
50,300 $3.41 Million
Q2 2023

Aug 09, 2023

SELL
$69.91 - $75.81 $368,076 - $399,139
-5,265 Reduced 8.75%
54,937 $3.93 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $304,319 - $345,040
4,819 Added 8.7%
60,202 $4.18 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $1.56 Million - $2.02 Million
-28,711 Reduced 34.14%
55,383 $3.75 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $1.7 Million - $4.35 Million
32,054 Added 61.59%
84,094 $5,000
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $361,900 - $434,451
-6,107 Reduced 10.5%
52,040 $3.44 Million
Q1 2022

May 13, 2022

SELL
$55.72 - $67.12 $224,384 - $270,292
-4,027 Reduced 6.48%
58,147 $3.86 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $180,210 - $212,936
-3,336 Reduced 5.09%
62,174 $3.62 Million
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $447,091 - $489,177
8,047 Added 14.0%
65,510 $3.94 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $509,087 - $632,732
10,514 Added 22.39%
57,463 $3.44 Million
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $79,841 - $92,166
-1,693 Reduced 3.48%
46,949 $2.33 Million
Q4 2020

Feb 17, 2021

BUY
$48.52 - $58.02 $2.05 Million - $2.46 Million
42,318 Added 669.17%
48,642 $2.43 Million
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $335,614 - $386,396
6,324 New
6,324 $347,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.